# The real world use of combined P-glycoprotein and moderate CYP3A4 inhibitors with rivaroxaban or apixaban increases bleeding

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-real-world-use-of-combined-p-glycoprotein-and-moderate-cyp3a4-inhibitors/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Sarah Hanigan,Jessica Das,Kristen Pogue,Geoffrey D. Barnes,Michael P. Dorsch |
| Citations | 90 |
| DOI | 10.1007/s11239-020-02037-3 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W3000465118 |
| PMID | 31925665 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Sarah Hanigan](https://scholariq.org/researchers/sarah-hanigan/)
- [Kristen Pogue](https://scholariq.org/researchers/kristen-pogue/)
- [Michael P. Dorsch](https://scholariq.org/researchers/michael-p-dorsch/)

## Paper primary topic

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)

## Paper topics

- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.